Peripheral orbital atherectomy systems Market Size, Sales, Average Price and Trends Analysis, till 2032

Peripheral orbital atherectomy systems Market Size is estimated to be $280million in 2024 and is expected to grow at an average yearly rate of around 4.5% during the timeframe (2025-2032).

Monitor Country-wise Peripheral orbital atherectomy systems Sales and Demand with Our Comprehensive Peripheral orbital atherectomy systems Sales Database

Gain in-depth insights into the Peripheral orbital atherectomy systems Sales landscape across 20+ countries with our specialized Peripheral orbital atherectomy systems Sales Database. Stay ahead in the market by tracking country-wise Peripheral orbital atherectomy systems Sales, identifying key manufacturers.

Extensive Peripheral orbital atherectomy systems Sales database covering 20+ countries worldwide, Peripheral orbital atherectomy systems Sales trends

Peripheral orbital atherectomy systems market revenue tracker by country

Stay Updated with Peripheral orbital atherectomy systems Sales Trends

Track real-time Peripheral orbital atherectomy systems prices, analyze Peripheral orbital atherectomy systems price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Peripheral orbital atherectomy systems Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/peripheral-orbital-atherectomy-systems-marke/



Peripheral orbital atherectomy systems sales trend in 2024 vs 2025

Peripheral Orbital Atherectomy Systems (POAS) are crucial medical devices used in the treatment of peripheral artery disease (PAD), particularly for patients with calcified lesions. These systems help restore blood flow by grinding away hardened plaque in arteries, offering a minimally invasive alternative to bypass surgery or stents. Between 2024 and 2025, the POAS market showed a dynamic shift, moving from steady performance to accelerated growth, influenced by multiple factors including innovation, regulatory shifts, and market expansion.

Sales Trend in 2024: Stabilization and Maturity

In 2024, the POAS market experienced moderate growth, indicating a period of maturity. Sales were stable, reflecting a well-established user base of vascular surgeons and interventional cardiologists familiar with the benefits of orbital atherectomy. Many hospitals and outpatient centers had already integrated these systems into their vascular care pathways. As a result, most of the demand came from routine usage rather than new adoptions.

Clinical confidence in POAS remained high due to their proven ability to treat complex arterial conditions, especially in aging populations. However, the year lacked groundbreaking innovations, which somewhat limited fresh momentum. Cost was another constraining factor, particularly in price-sensitive regions or systems with limited reimbursement frameworks. Additionally, competition from alternative PAD treatments, such as drug-coated balloons and laser atherectomy, kept the market highly competitive.

Despite these hurdles, ongoing educational initiatives and consistent procedural success helped maintain a healthy but unspectacular sales pace throughout 2024.

Sales Trend in 2025: Renewed Growth and Expansion

In 2025, the POAS market transitioned from stabilization to a phase of renewed and accelerated growth. This shift was largely driven by the introduction of next-generation devices with enhanced functionality. Manufacturers responded to physician feedback by developing systems with improved maneuverability, better debris capture mechanisms, and more efficient plaque removal. These advancements increased physician confidence and allowed more complex cases to be treated successfully.

Another major driver was regulatory expansion. POAS received approvals for broader use in different arterial territories, which widened their applicability and created new clinical opportunities. Moreover, emerging healthcare markets, particularly in Asia and Latin America, began to adopt POAS technology more rapidly due to growing awareness and investment in vascular care infrastructure.

The competitive landscape also evolved, with strategic partnerships between device manufacturers and healthcare institutions leading to more aggressive training programs and adoption incentives. Hospitals that previously hesitated due to cost or unfamiliarity were more inclined to invest in POAS thanks to bundled packages, technical support, and clearer long-term cost-effectiveness data.

Marketing strategies in 2025 also became more patient-focused, emphasizing outcomes like limb salvage and quality of life, which resonated with both clinicians and healthcare administrators. This narrative helped drive interest in early PAD intervention, further boosting procedural volume.

Request for customization https://datavagyanik.com/reports/peripheral-orbital-atherectomy-systems-marke/



Peripheral orbital atherectomy systems Market Definition
Peripheral Orbital Atherectomy Systems (POAS) represent a specialized segment within the broader vascular intervention and medical devices market. These systems are designed to treat peripheral artery disease (PAD), a condition where plaque buildup narrows or blocks arteries, primarily in the legs. PAD affects millions of people worldwide and is associated with serious complications such as pain, mobility loss, and even limb amputation. The POAS market focuses on delivering solutions for the effective removal of calcified plaque in peripheral arteries, helping restore blood flow and prevent disease progression.

Core Definition of the Market

The POAS market is defined by a range of medical devices that use orbital motion to grind away hardened plaque within peripheral arteries. Unlike traditional balloon angioplasty or stents, orbital atherectomy relies on a diamond-coated rotating crown that sands down plaque without damaging the artery wall. These systems are typically used in minimally invasive procedures performed in hospitals, outpatient clinics, and specialized catheterization labs.

This market includes the devices themselves, accessories such as guide wires and lubricants, and related services including device training, maintenance, and post-sale support. It also encompasses the technology platforms on which these systems operate, including control units and monitoring interfaces used by physicians during procedures.

Segmentation Within the Market

The POAS market can be segmented in several ways:

By Product Type:
Devices are typically categorized based on crown size, shaft flexibility, and compatibility with different vessel types.

By End User:
The main users are hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Larger hospitals may use POAS more frequently due to higher patient volumes and better access to advanced technology.

By Geography:
The market varies significantly by region. North America currently leads in adoption due to strong healthcare infrastructure, while Asia-Pacific is a rapidly growing segment due to increasing awareness and healthcare investments.

By Application:
While primarily used in the lower limbs, technological improvements are enabling their use in upper extremity vessels and even more distal arteries.

Key Characteristics of the Market

The POAS market is technology-driven and innovation-sensitive. It is highly competitive, with both established medical device companies and emerging players vying for market share through better performance, lower costs, and broader clinical applications. Regulatory approvals, especially from agencies like the FDA or CE, heavily influence market entry and expansion.

Furthermore, clinical outcomes play a central role in market growth. Devices that demonstrate lower complication rates, shorter recovery times, and higher long-term vessel patency are more likely to succeed. Additionally, reimbursement policies greatly impact adoption rates, making health economics a vital factor in the market definition.

Market Outlook and Importance

The importance of the POAS market is expected to grow as the global population ages and the prevalence of PAD increases. With rising demand for minimally invasive and effective treatments, the market continues to expand in both size and complexity. Innovation, combined with improved clinical education and accessibility, positions the POAS market as a key component of the future of peripheral vascular care.

Important target segments driving the demand for Peripheral orbital atherectomy systems Market

Peripheral Orbital Atherectomy Systems (POAS) are gaining traction as a vital tool in the treatment of peripheral artery disease (PAD). These systems are designed to remove calcified plaque in peripheral arteries, enabling smoother blood flow and reducing the risk of complications such as limb amputation. As awareness of PAD increases and minimally invasive technologies evolve, certain market segments have emerged as key drivers of demand for POAS. Understanding these target segments is essential to grasp how the market is expanding and where future growth opportunities lie.

1. Aging Population with PAD

One of the most significant demand drivers is the growing elderly population. Aging is directly linked to an increased risk of atherosclerosis and calcified peripheral arteries. Patients over the age of 65 are far more likely to develop PAD due to long-term exposure to risk factors like hypertension, diabetes, and high cholesterol. These individuals often present with complex, calcified lesions that are difficult to treat with conventional angioplasty alone. POAS offers an effective, minimally invasive solution for this patient group, making them a key target segment.

2. Patients with Diabetes and Chronic Kidney Disease

Patients suffering from diabetes or chronic kidney disease (CKD) represent another major segment. These individuals often experience accelerated vascular calcification, particularly in the lower limbs. Traditional endovascular techniques may be less effective or riskier for these patients, making POAS a more suitable option due to its precision and ability to treat heavily calcified lesions. As the prevalence of diabetes continues to rise globally, especially in urban and developing areas, this segment's impact on market demand is expected to grow significantly.

3. Vascular Surgery and Interventional Radiology Centers

Healthcare providers such as vascular surgery departments and interventional radiology centers are important institutional buyers of POAS. These centers are typically well-equipped and staffed by specialists trained in advanced endovascular procedures. They are more likely to adopt new technologies, particularly when those technologies demonstrate better patient outcomes and procedural success rates. As these centers aim to reduce hospital stays and improve recovery times, POAS fits well into their treatment protocols, driving consistent demand.

4. Ambulatory Surgical Centers (ASCs)

Ambulatory Surgical Centers are becoming a critical segment due to the healthcare industry's shift toward cost-effective, outpatient procedures. ASCs often focus on high-efficiency, minimally invasive treatments, and POAS is well-suited for this setting. As reimbursement models and regulatory approvals continue to favor outpatient care, ASCs will likely become a growing segment for POAS adoption, offering both clinical and economic benefits.

5. Healthcare Providers in Emerging Markets

Developing countries, particularly in Asia-Pacific and Latin America, are witnessing a growing burden of PAD due to changing lifestyles and rising rates of obesity and diabetes. As healthcare systems in these regions invest in advanced vascular care and training, demand for POAS is beginning to rise. These markets represent a long-term growth opportunity and are being actively targeted by manufacturers through strategic pricing and education programs.



Key Players in Peripheral orbital atherectomy systems , Market Share

The Peripheral Orbital Atherectomy Systems (POAS) market is a specialized segment within the broader atherectomy devices industry, focusing on minimally invasive solutions for treating peripheral artery disease (PAD). Several key players dominate this market, leveraging technological advancements, strategic acquisitions, and global distribution networks to maintain and expand their market share.

Leading Companies in the POAS Market

Medtronic

Medtronic holds a substantial share in the POAS market, offering a robust portfolio of rotational and orbital atherectomy devices. The company's commitment to innovation and global reach solidifies its position as a market leader.

Boston Scientific Corporation

Boston Scientific is a prominent player, known for its innovative laser atherectomy technologies. The company's focus on product development and strategic partnerships contributes to its significant market presence.

Cardiovascular Systems Inc. (CSI)

CSI specializes in developing novel atherectomy systems, including the Diamondback 360 Precision Orbital Atherectomy System. The company's dedication to treating peripheral and coronary artery diseases positions it as a key competitor.

Abbott Laboratories

Abbott has expanded its presence in the POAS market through strategic acquisitions, notably the purchase of Cardiovascular Systems Inc. in April 2023. This move enhances Abbott's capabilities in treating peripheral and coronary diseases.

Koninklijke Philips N.V.

Philips offers advanced atherectomy systems catering to a wide range of cardiovascular conditions. The company's emphasis on innovation and global distribution supports its competitive position.

Terumo Corporation

Terumo is a significant player in the POAS market, providing a range of atherectomy devices. The company's focus on quality and technological advancement contributes to its market share.

Market Share Insights

While exact market share percentages are proprietary and vary by region, the aforementioned companies collectively dominate the POAS market. Their leadership is attributed to continuous product innovation, strategic mergers and acquisitions, and expansive global distribution networks.

The market is characterized by intense competition, with companies striving to differentiate themselves through technological advancements and improved clinical outcomes. Emerging players are also entering the market, focusing on niche segments and innovative solutions to gain a foothold.



Key Questions Answered in the Peripheral orbital atherectomy systems market report:

What is the total global Peripheral orbital atherectomy systems Sales volume, and how has it changed over the past five years?

What is Peripheral orbital atherectomy systems price trend, what has been the historical prices?

What will be the Peripheral orbital atherectomy systems price trend in 2025?

Which countries have the highest Peripheral orbital atherectomy systems Sales, and what factors contribute to their dominance in the market?

How does Peripheral orbital atherectomy systems Sales vary across key manufacturers, and what expansions have been observed recently?

What is the current global revenue generated from Peripheral orbital atherectomy systems Sales, and how does it compare to previous years?

Which industries drive the highest demand for Peripheral orbital atherectomy systems , and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Peripheral orbital atherectomy systems Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Peripheral orbital atherectomy systems Sales and market dynamics?

Related Studies:

Epilepsy depth electrodes Market
https://datavagyanik.com/reports/epilepsy-depth-electrodes-market/

Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) devices Market
https://datavagyanik.com/reports/endoscopic-ultrasound-guided-fine-needle-aspiration-eus-fna-devices-market/

Lumbar Catheters Market
https://datavagyanik.com/reports/lumbar-catheters-market-size-production-sales-average-product-price-market-share-import-vs-export/

Osteochondral implants Market
https://datavagyanik.com/reports/osteochondral-implants-market/

Esophageal dilation balloon catheters Market
https://datavagyanik.com/reports/esophageal-dilation-balloon-catheters-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/
Email: sales@datavagyanik.com

This release was published on openPR.